U.S. Department of Health and Human Services
Close
Updated Perinatal Guidelines
On Friday, December 7, 2018 the HHS Panel on Treatment of Pregnant Women with HIV Infection and Prevention of Perinatal Transmission released an updated version of the Recommendations for the Use of Antiretroviral Drugs in Pregnant Women with HIV Infection and Interventions to Reduce Perinatal HIV Transmission in the United States.
Feedback on the revised guidelines is welcome. Please email your comments with the subject line “Comments on the Perinatal Guidelines” to ContactUs@aidsinfo.nih.gov by December 20, 2018.Recommendations for the Use of Antiretroviral Drugs in Pregnant Women with HIV Infection and Interventions to Reduce Perinatal HIV Transmission in the United States
- Home
- Guidelines
- Perinatal
- Table 10. Antiretroviral Drug Use in Pregnant Women with HIV Infection: Pharmacokinetic and Toxicity Data in Human Pregnancy and Recommendations for Use in Pregnancy
The information in the brief version is excerpted directly from the full-text guidelines. The brief version is a compilation of the tables and boxed recommendations.
- Table of Contents
- What's New in the Guidelines
- Guidelines Panel Members
- Financial Disclosure
- Introduction
- Maternal HIV Testing and Identification of Perinatal HIV Exposure
- Counseling and Management of Women Living with HIV Who Breastfeed
- Preconception Counseling and Care for Women of Childbearing Age Living with HIV
-
Antepartum Care
- General Principles Regarding Use of Antiretroviral Drugs during Pregnancy
-
Recommendations for Use of Antiretroviral Drugs During Pregnancy
- Overview
- Pregnant Women Living with HIV Who Have Never Received Antiretroviral Drugs (Antiretroviral Naive)
- Table 6. What to Start: Initial Combination Regimens for Antiretroviral-Naive Pregnant Women
- Table 7. Situation-Specific Recommendations for Use of ARVs
- Pregnant Women Living with HIV Who Are Currently Receiving Antiretroviral Therapy
- Pregnant Women Living with HIV Who Have Previously Received Antiretroviral Treatment or Prophylaxis but Are Not Currently Receiving Any Antiretroviral Medications
- Monitoring of the Woman and Fetus During Pregnancy
- Antiretroviral Drug Resistance and Resistance Testing in Pregnancy
- Lack of Viral Suppression
- Stopping Antiretroviral Drugs During Pregnancy
- Special Populations
- Intrapartum Care
- Postpartum Follow-Up of Women Living with HIV Infection
- Management of Infants Born to Women with HIV Infection
- Appendix A: Review of Clinical Trials of Antiretroviral Interventions to Prevent Perinatal HIV Transmission
-
Appendix B: Supplement: Safety and Toxicity of Individual Antiretroviral Agents in Pregnancy
- Table 10. ARV Drug Use in Pregnant HIV-Infected Women
- Nucleoside and Nucleotide Analogue Reverse Transcriptase Inhibitors
- Non-Nucleoside Reverse Transcriptase Inhibitors
- Protease Inhibitors
- Entry and Attachment Inhibitors
- Integrase Inhibitors
- Pharmacoenhancers
- Antiretroviral Pregnancy Registry
- Appendix C: Acronyms
Download Guidelines
- Section Only PDF (425 KB)
- Full Guideline PDF ()
- Recommendations Only PDF (211 KB)
- Tables Only PDF (388 KB)
Related Content
- AIDSinfo Drug Database
- AIDSinfo Patient Materials: Preventing Mother-to-Child Transmission of HIV
- AIDSinfo Patient Materials: HIV Medicines During Pregnancy and Childbirth
- AIDSinfo Patient Materials: Protecting Baby from HIV
- AETC National HIV Curriculum
- How to Cite These Guidelines
- Perinatal Guidelines Archive
Appendix B: Supplement: Safety and Toxicity of Individual Antiretroviral Agents in Pregnancy
Table 10. Antiretroviral Drug Use in Pregnant Women with HIV Infection: Pharmacokinetic and Toxicity Data in Human Pregnancy and Recommendations for Use in Pregnancy
Last Updated: December 7, 2018; Last Reviewed: December 7, 2018
Download Guidelines
- Section Only PDF (425 KB)
- Full Guideline PDF ()
- Recommendations Only PDF (211 KB)
- Tables Only PDF (388 KB)
Related Content
- AIDSinfo Drug Database
- AIDSinfo Patient Materials: Preventing Mother-to-Child Transmission of HIV
- AIDSinfo Patient Materials: HIV Medicines During Pregnancy and Childbirth
- AIDSinfo Patient Materials: Protecting Baby from HIV
- AETC National HIV Curriculum
- How to Cite These Guidelines
- Perinatal Guidelines Archive
Email Updates
